Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Klaassen

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Canadian Medical Association Journal|November 19, 1977
Present status of cancer chemotherapyD J Klaassen
Cancer Investigation|May 16, 2000
Unresectable adenocarcinoma of the pancreasD J Klaassen
Canadian Journal of Surgery. Journal Canadien De Chirurgie|May 1, 1978
Chemotherapy of colorectal cancerD J Klaassen
Canadian Medical Association Journal|March 24, 2010
Leukemia in SaskatchewanD J Klaassen
International Journal of Clinical Pharmacology, Therapy and Toxicology|January 1, 1974
Combination chemotherapy in disseminated solid tumoursD J Klaassen
Cancer Chemotherapy Reports|September 1, 1974
Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancerD J Klaassen, E Rapp
Cancer Chemotherapy and Pharmacology|January 1, 1981
A phase II study of m-AMSA in patients with primary liver cancerG Falkson, B Coetzer, D J Klaassen
Cancer Treatment Reports|March 1, 1976
Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal womenD J Klaassen, E F Rapp, W E Hirte
Chest|November 1, 1990
Determinants of cell type in patients with cancer of the lungsH H McDuffie, D J Klaassen, J A Dosman
Cancer Chemotherapy and Pharmacology|January 1, 1983
Inhibition of human breast cancer colony formation by anticalmodulin agents: trifluoperazine, W-7, and W-13J W Wei, R A Hickie, D J Klaassen
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Canadian Medical Association Journal|November 19, 1977
Present status of cancer chemotherapyD J Klaassen
Cancer Investigation|May 16, 2000
Unresectable adenocarcinoma of the pancreasD J Klaassen
Canadian Journal of Surgery. Journal Canadien De Chirurgie|May 1, 1978
Chemotherapy of colorectal cancerD J Klaassen
Canadian Medical Association Journal|March 24, 2010
Leukemia in SaskatchewanD J Klaassen
International Journal of Clinical Pharmacology, Therapy and Toxicology|January 1, 1974
Combination chemotherapy in disseminated solid tumoursD J Klaassen
Cancer Chemotherapy Reports|September 1, 1974
Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancerD J Klaassen, E Rapp
Cancer Chemotherapy and Pharmacology|January 1, 1981
A phase II study of m-AMSA in patients with primary liver cancerG Falkson, B Coetzer, D J Klaassen
Cancer Treatment Reports|March 1, 1976
Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal womenD J Klaassen, E F Rapp, W E Hirte
Chest|November 1, 1990
Determinants of cell type in patients with cancer of the lungsH H McDuffie, D J Klaassen, J A Dosman
Cancer Chemotherapy and Pharmacology|January 1, 1983
Inhibition of human breast cancer colony formation by anticalmodulin agents: trifluoperazine, W-7, and W-13J W Wei, R A Hickie, D J Klaassen
Pageof 4